Foundation Fighting Blindness
@fightblindness.bsky.social
We are the driving force in the global development of treatments and cures for blinding diseases.
Save the date! United in Vision 2026 combines the VISIONS Conference & Retina International World Congress. Join us June 10-13, 2026, in Fort Worth, TX, for collaboration, innovation & hope. 💙
Learn more: www.FightingBlindness.org/VISIONS2026
Learn more: www.FightingBlindness.org/VISIONS2026
VISIONS 2026: United in Vision
The United in Vision 2026 conference unites two prestigious events—the Foundation Fighting Blindness VISIONS conference and the Retinal International World Congress—into one extraordinary global gathering. Scheduled from Wednesday, June 10, to Saturday, June 13, 2026, at the Omni Fort Worth Hotel and Fort Worth Convention Center in Fort Worth, Texas.
www.FightingBlindness.org
April 1, 2025 at 6:04 PM
Save the date! United in Vision 2026 combines the VISIONS Conference & Retina International World Congress. Join us June 10-13, 2026, in Fort Worth, TX, for collaboration, innovation & hope. 💙
Learn more: www.FightingBlindness.org/VISIONS2026
Learn more: www.FightingBlindness.org/VISIONS2026
Reposted by Foundation Fighting Blindness
This month in @arvoinfo.bsky.social IOVS journal, review the largest assessment across multiple continents of genetic causality in the patient population of #InheritedRetinalDiseases: bit.ly/42Jej2V
@fightblindness.bsky.social #ARVOjournals #OpenAccess
@fightblindness.bsky.social #ARVOjournals #OpenAccess
February 5, 2025 at 9:40 PM
This month in @arvoinfo.bsky.social IOVS journal, review the largest assessment across multiple continents of genetic causality in the patient population of #InheritedRetinalDiseases: bit.ly/42Jej2V
@fightblindness.bsky.social #ARVOjournals #OpenAccess
@fightblindness.bsky.social #ARVOjournals #OpenAccess
Reposted by Foundation Fighting Blindness
The RI Education Hub continued today with two excellent presentations on Patient Registries from Russell Wheeler and Todd Durham @fightblindness.bsky.social. Thanks to our speakers and participants for their participation and engagement #IRD #Genetics #GeneticTesting #Registries #ClinicalTrials
February 7, 2025 at 1:05 PM
The RI Education Hub continued today with two excellent presentations on Patient Registries from Russell Wheeler and Todd Durham @fightblindness.bsky.social. Thanks to our speakers and participants for their participation and engagement #IRD #Genetics #GeneticTesting #Registries #ClinicalTrials
Age-related macular degeneration (AMD) affects millions, causing central vision loss. This simulation offers a glimpse into what those living with AMD may experience.
February 6, 2025 at 7:24 PM
Age-related macular degeneration (AMD) affects millions, causing central vision loss. This simulation offers a glimpse into what those living with AMD may experience.
Meet Eva. Eva Watson’s life was marked by her dedication to advancing research for blinding diseases. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases.
Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW
Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW
Eva Lou Schroeder Watson's Enduring Legacy
Eva Watson's life was marked by her dedication to advancing medical research for blinding diseases, and her generous bequest to the Foundation Fighting Blindness ensures her advocacy will endure. Her ...
bit.ly
January 29, 2025 at 9:26 PM
Meet Eva. Eva Watson’s life was marked by her dedication to advancing research for blinding diseases. Her story highlights the profound impact of her contributions to driving treatments and cures for blinding diseases.
Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW
Read Eva's full Beacon Story on our website at: bit.ly/4gawEZW
Nacuity Pharmaceuticals granted U.S. FDA fast track designation for NPI-001 (N-acetylcysteine amide) tablets for the treatment of retinitis pigmentosa.
Read more on our website at: bit.ly/3E3pfhv
Read more on our website at: bit.ly/3E3pfhv
Nacuity Pharmaceuticals Granted U.S. FDA Fast Track Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
bit.ly
January 22, 2025 at 8:01 PM
Nacuity Pharmaceuticals granted U.S. FDA fast track designation for NPI-001 (N-acetylcysteine amide) tablets for the treatment of retinitis pigmentosa.
Read more on our website at: bit.ly/3E3pfhv
Read more on our website at: bit.ly/3E3pfhv
Mark your calendars! The Retinal Therapeutics Innovation Summit 2025 is happening on May 2 in Salt Lake City, UT!
Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications.
Seating is limited to 500—reserve now! bit.ly/4hhIOBa
Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications.
Seating is limited to 500—reserve now! bit.ly/4hhIOBa
Retinal Therapeutics Innovation Summit 2025
{{MetaTags.description}}
bit.ly
January 17, 2025 at 7:43 PM
Mark your calendars! The Retinal Therapeutics Innovation Summit 2025 is happening on May 2 in Salt Lake City, UT!
Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications.
Seating is limited to 500—reserve now! bit.ly/4hhIOBa
Hear from top experts, discuss emerging therapies, and strategize solutions to accelerate clinical applications.
Seating is limited to 500—reserve now! bit.ly/4hhIOBa
Spring into action, VisionWalkers!
Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo!
Sign up today at www.VisionWalk.org!
Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo!
Sign up today at www.VisionWalk.org!
VisionWalk
VisionWalk Home Page
www.VisionWalk.org
January 16, 2025 at 6:32 PM
Spring into action, VisionWalkers!
Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo!
Sign up today at www.VisionWalk.org!
Register your team for your local Spring #VisionWalk by February 1st and you’ll be entered to win an unforgettable prize: lunch with our CEO, Jason Menzo!
Sign up today at www.VisionWalk.org!
Today, we're happy to share the incredible journey of blind hockey players in New Jersey, as highlighted in the NJ Herald. This inspiring article features athletes breaking barriers and redefining what’s possible on the rink.
Read the full article at: bit.ly/3DYu63K
Read the full article at: bit.ly/3DYu63K
'Finding your community': NJ blind hockey team looking for more players
Josh Schneider lost 98% of his eyesight and retired from teaching at age 37. Then he found blind hockey with Jersey Blind.
www.njherald.com
January 15, 2025 at 7:28 PM
Today, we're happy to share the incredible journey of blind hockey players in New Jersey, as highlighted in the NJ Herald. This inspiring article features athletes breaking barriers and redefining what’s possible on the rink.
Read the full article at: bit.ly/3DYu63K
Read the full article at: bit.ly/3DYu63K